The convenience of subcutaneous route of drug administration and the reformulation of intravenous drugs, reaching patent expiry, for SC delivery has provided an impetus to the development of large volume wearable injectors. In fact, according to the experts in this field, the industry is putting in significant efforts to develop efficient and effective drug-device combinations to deliver large volumes of drugs over a convenient period of time.
To order this 540+ page report, which features 175+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors/238.html
The USD 2.7 billion and USD 600 million (by 2030) financial opportunity within the large volume wearable injectors market for the delivery of insulin and of non-insulin drugs, respectively, has been analyzed across the following segments:
Type of Device
Patch Pump / Injectors
Infusion Pump / Injectors
Product Usability
Disposable
Re-usable
Therapeutic Area (for non-insulin drugs)
Neurological Disorders
Cardiovascular Disorders
Oncological Disorders
Infectious Disorders
Key geographical regions
North America
Europe
Asia Pacific
The report Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices.” features the following companies, which we identified to be key players in this domain:
Becton Dickinson
Bespak (subsidiary of Consort Medical)
CeQur
Debiotech
Eli Lilly
Enable Injections
Insulet
Medtronic
PharmaSens
Roche
SOOIL Development
Sonceboz
Sensile Medical (acquired by Gerresheimer)
SteadyMed Therapeutics (acquired by United Therapeutics)
Tandem Diabetes Care
Weibel CDS (acquired by SHL Medical)
West Pharmaceutical Services
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Large Volume Wearable Injectors: Current Market Landscape
5. Product Competitiveness Analysis
6. Large Volume Wearable Injectors: Key Players
7. Drug Device Combinations: Tabulated Profiles
8. Partnerships and Collaborations
9. Key Acquisition Targets
10. Patent Analysis
11. Large Volume Wearable Injectors: Likely Drug Candidates
12. Emerging Trends on Social Media
13. Clinical Trial Analysis
14. Case Study: Role of CMOs in Device Development and Manufacturing
15. Regulatory and Reimbursement Landscape for Medical Devices
16. Market Sizing and Opportunity Analysis
17. SWOT Analysis
18. Executive Insights
19. Appendix 1: Tabulated Data
20. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors-market-4th-edition-2018-2030/238.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]